← Back to Search

Novel Wearable Device for Hypoxia

N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Suspected to suffer from hypoxic events
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15-20 minutes depending on the patients questions.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how well a new device prototype works in measuring oxygen and movement.

Who is the study for?
This trial is for adults over 21 who can give informed consent and are suspected to experience low oxygen levels (hypoxia). Pregnant individuals cannot participate.
What is being tested?
The study is testing the functionality of a new wearable device's components: an FDA approved pulse oximeter, which measures oxygen levels in blood, and an accelerometer that tracks movement.
What are the potential side effects?
Since this trial involves non-invasive monitoring with a wearable device, significant side effects are not expected. However, minor skin irritation or discomfort from wearing the device may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I might have had episodes where my body didn't get enough oxygen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15-20 minutes depending on the patients questions.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15-20 minutes depending on the patients questions. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Comparing Dove device against FDA approved SpO2 sensor
Secondary study objectives
Questionnaire about comfort of device

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Assess device prototype functionalityExperimental Treatment1 Intervention
Everyone will be in the same arm

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,493 Total Patients Enrolled

Media Library

Assess device prototype functionality Clinical Trial Eligibility Overview. Trial Name: NCT05197790 — N/A
Low Oxygen Levels Research Study Groups: Assess device prototype functionality
Low Oxygen Levels Clinical Trial 2023: Assess device prototype functionality Highlights & Side Effects. Trial Name: NCT05197790 — N/A
Assess device prototype functionality 2023 Treatment Timeline for Medical Study. Trial Name: NCT05197790 — N/A
~11 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top